Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$43,750.00

Delineating the effects of extra chromosome 21 of Down syndrome on microRNA and protein levels for discovery of novel biomarkers

EF 2008-09

Résumé
The chance of having a baby with Down syndrome increases with advanced maternal age. Currently available screening for Down syndrome consists of maternal serum test, which measures the levels of three to four proteins in the mother's blood. However, due to many false-positive or false-negative test results, many mothers need to be further tested by a test called amniocentesis, which is an invasive procedure that obtains amniotic fluid by puncturing the abdominal and uterine walls. This test involves miscarriage rate of 0.5%, and it takes at least 10 days for the results to come out, causing anxiety from the family. Our group has previously analyzed human amniotic fluid and identified approximately 800 proteins from this fluid, and now we focus on the proteins that show aberrant expression in the cases of Down syndrome to improve current screening tests. Moreover, we aim to understand the genetic mechanisms of Down syndrome. Even though it has long been known that Down syndrome is caused due to an extra chromosome, detailed mechanisms have not been understood so that there has been no room for the therapeutic research for Down syndrome-affected individuals.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184357
Name
Cho Chan-Kyung J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Delineating the effects of extra chromosome 21 of Down syndrome on microRNA and protein levels for discovery of novel biomarkers
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$43,750
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Amniocyte; Amniotic Fluid; Chromosome 21 Genes; Chromosome 21 Mirna; Down Syndrome; Elisa; Mass Spectrometry; Maternal Serum Marker; Proteomic Analysis; Quantitative Proteomics; Silac
Abstract
The chance of having a baby with Down syndrome increases with advanced maternal age. Currently available screening for Down syndrome consists of maternal serum test, which measures the levels of three to four proteins in the mother's blood. However, due to many false-positive or false-negative test results, many mothers need to be further tested by a test called amniocentesis, which is an invasive procedure that obtains amniotic fluid by puncturing the abdominal and uterine walls. This test involves miscarriage rate of 0.5%, and it takes at least 10 days for the results to come out, causing anxiety from the family. Our group has previously analyzed human amniotic fluid and identified approximately 800 proteins from this fluid, and now we focus on the proteins that show aberrant expression in the cases of Down syndrome to improve current screening tests. Moreover, we aim to understand the genetic mechanisms of Down syndrome. Even though it has long been known that Down syndrome is caused due to an extra chromosome, detailed mechanisms have not been understood so that there has been no room for the therapeutic research for Down syndrome-affected individuals.
Competitiondate
200810
Approvedterm2
1 yr 3 mths
Pinamesdelim
Cho, Chan-Kyung J
Approvedterm
1 an 3 mois
Cihrcontribution2
~ $43,750~ $0~